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Background
Primary systemic vasculitides (PSV) in childhood are
rare but are associated with high morbidity/mortality.
We adapted the adult Birmingham Vasculitis Activity
Score (BVAS3), for use in childhood vasculitis: the Pae-
diatric Vasculitis Activity Score (PVAS).
Aim
To develop and validate PVAS based on modifications
of BVAS3, and to establish an effective training system
for use of PVAS according to the recommendations of
the European Vasculitis Study Group (EUVAS).
Methods
The PRINTO vasculitis classification registry was
reviewed for the presence of items not included in the
original nine organ systems in BVAS3; items that were
present in ≥ 20% of patients were added. Critical review
of these items by a working group of paediatric rheuma-
tologists with an interest in vasculitis resulted in the
first version of PVAS. During consensus meetings con-
tent and face validity was established, resulting in minor
modifications to the PVAS and its glossary. The score
weightings were unchanged from BVAS3 resulting in
the same range of numeric scores: 0-63, where zero
indicates no vasculitis disease activity. Twenty paediatric
paper training cases were prepared for the initial tool
assessment.
Results
Eight paediatric-relevant items and their definitions were
added to the original BVAS3 in the cutaneous (4),
cardiovascular (3) and abdominal (1) systems. The final
score for each organ system remained unchanged. Addi-
tionally, 22/56 BVAS3 items were re-defined for paedia-
tric use, including definitions of weight loss and renal
manifestations. Based on an ideal consensus answer for
each of the 20 paper cases 9/11 investigators reached
>85% agreement. The main cause of disagreement was
the failure to record the absence of any items within a
category.
Conclusion
PVAS development marks an important international
collaborative step towards a systematic and reliable clin-
ical score of vasculitis disease activity for children.
Ongoing work is assessing the utility of PVAS in real
paediatric vasculitis patients, with the ultimate aim of
using PVAS in routine clinical practice, and as a disease
outcome measure in future clinical trials.
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